Citation 105135

FOTSIS,T: PEPPER,MS: AKTAS,E: BREIT,S: RASKU,S: ADLERCREUTZ,H: WAHALA,K: MONTESANO,R: SCHWEIGERER,L:. (1997). FLAVONOIDS, DIETARY-DERIVED INHIBITORS OF CELL PROLIFERATION AND IN VITRO ANGIOGENESIS.. 57(14)

Citation Details

Title	FLAVONOIDS, DIETARY-DERIVED INHIBITORS OF CELL PROLIFERATION AND IN VITRO ANGIOGENESIS.
Authors	FOTSIS,T: PEPPER,MS: AKTAS,E: BREIT,S: RASKU,S: ADLERCREUTZ,H: WAHALA,K: MONTESANO,R: SCHWEIGERER,L:
Year	1997
Volume	57
Issue	14

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	WEAK ACTIVITY
2	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,5-METHOXY:	WEAK ACTIVITY
3	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	WEAK ACTIVITY
4	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	EQUIVOCAL
5	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	WEAK ACTIVITY
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CHRYSIN	WEAK ACTIVITY
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CHRYSIN	WEAK ACTIVITY
8	ANGIOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,2'-3'-DIHYDROXY:	ACTIVE
9	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3'-4'-DIHYDROXY:	ACTIVE
10	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3'-4'-DIHYDROXY:	WEAK ACTIVITY
11	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3'-4'-DIHYDROXY:	ACTIVE
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,3'-4'-DIHYDROXY:	ACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,3'-4'-DIHYDROXY:	WEAK ACTIVITY
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,3'-4'-DIHYDROXY:	ACTIVE
15	ANGIOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3'-4'-DIHYDROXY:	ACTIVE
16	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	WEAK ACTIVITY
17	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	WEAK ACTIVITY
18	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	WEAK ACTIVITY
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	APIGENIN	ACTIVE
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	APIGENIN	ACTIVE
21	ANGIOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE
22	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
23	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	WEAK ACTIVITY
24	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LUTEOLIN	WEAK ACTIVITY
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LUTEOLIN	ACTIVE
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LUTEOLIN	ACTIVE
28	ANGIOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
29	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYNAROSIDE	WEAK ACTIVITY
30	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYNAROSIDE	WEAK ACTIVITY
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYNAROSIDE	WEAK ACTIVITY
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYNAROSIDE	ACTIVE
33	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	EQUIVOCAL
34	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
35	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HESPERETIN	EQUIVOCAL
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HESPERETIN	INACTIVE
38	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIODICTYOL	WEAK ACTIVITY
39	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIODICTYOL	INACTIVE
40	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIODICTYOL	WEAK ACTIVITY
41	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ERIODICTYOL	WEAK ACTIVITY
42	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ERIODICTYOL	WEAK ACTIVITY
43	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-HYDROXY:	ACTIVE
44	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-HYDROXY:	ACTIVE
45	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,3-HYDROXY:	ACTIVE
46	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,3-HYDROXY:	ACTIVE
47	ANGIOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-HYDROXY:	ACTIVE
48	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	WEAK ACTIVITY
49	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	EQUIVOCAL
50	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	EQUIVOCAL
51	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FISETIN	WEAK ACTIVITY
52	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FISETIN	WEAK ACTIVITY
53	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FISETIN	WEAK ACTIVITY
54	ANGIOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	ACTIVE
55	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	WEAK ACTIVITY
56	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	EQUIVOCAL
57	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
58	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	QUERCETIN	WEAK ACTIVITY
59	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	QUERCETIN	WEAK ACTIVITY
60	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	QUERCETIN	WEAK ACTIVITY
61	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MYRICETIN	EQUIVOCAL
62	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	EQUIVOCAL
63	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	EQUIVOCAL
64	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MYRICETIN	INACTIVE
65	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE
66	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE
67	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE
68	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CATECHIN,(+):	INACTIVE
69	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CATECHIN,(+):	INACTIVE
70	ANGIOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	EQUIVOCAL
71	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIN	INACTIVE
72	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIN	INACTIVE
73	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIN	INACTIVE
74	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN	INACTIVE
75	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN	INACTIVE

Citation 105135

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1